keyword
https://read.qxmd.com/read/38577256/cytokine-storm-syndrome-responsive-to-il-1-inhibition-in-trisomy-21
#21
Aimee Magnarelli, Julia Shalen, Maria J Gutierrez
BACKGROUND: Cytokine storm syndromes (CSS) are life-threatening systemic inflammatory disorders caused by immune system dysregulation. They can lead to organ failure and are triggered by various factors, including infections, malignancy, inborn errors of immunity, and autoimmune conditions. Trisomy 21 (TS21), also known as Down syndrome, is a genetic disorder associated with immune dysfunction, increased infection susceptibility, and inflammation. While TS21 has been linked to infectious-triggered hyperinflammation, its role as a primary cause of CSS has not been confirmed...
2024: Case Reports in Pediatrics
https://read.qxmd.com/read/38574930/therapeutic-potential-of-proteases-in-acute-lung-injury-and-respiratory-distress-syndrome-via-tlr4-nrf2-nf-kb-signaling-modulation
#22
JOURNAL ARTICLE
Hend Mohamed Anwar, Gad Elsayed Mohamed Salem, Hanan M Abd El-Latief, Amany Abd Elhameid Osman, Sahar K Ghanem, Haroon Khan, Suchana Chavanich, Alshaymaa Darwish
The COVID-19 pandemic has drawn attention to acute lung injury and respiratory distress syndrome as major causes of death, underscoring the urgent need for effective treatments. Protease enzymes possess a wide range of beneficial effects, including antioxidant, anti-inflammatory, antifibrotic, and fibrinolytic effects. This study aimed to evaluate the potential therapeutic effects of bacterial protease and chymotrypsin in rats in mitigating acute lung injury induced by lipopolysaccharide. Molecular docking was employed to investigate the inhibitory effect of bacterial protease and chymotrypsin on TLR-4, the receptor for lipopolysaccharide...
April 2, 2024: International Journal of Biological Macromolecules
https://read.qxmd.com/read/38573465/specific-and-non-specific-aspects-and-future-challenges-of-icu-care-among-covid-19-patients-with-obesity-a-narrative-review
#23
REVIEW
Alexandra Beurton, Emma J Kooistra, Audrey De Jong, Helmut Schiffl, Mercedes Jourdain, Bruno Garcia, Damien Vimpère, Samir Jaber, Peter Pickkers, Laurent Papazian
PURPOSE OF REVIEW: Since the end of 2019, the coronavirus disease 2019 (COVID-19) pandemic has infected nearly 800 million people and caused almost seven million deaths. Obesity was quickly identified as a risk factor for severe COVID-19, ICU admission, acute respiratory distress syndrome, organ support including mechanical ventilation and prolonged length of stay. The relationship among obesity; COVID-19; and respiratory, thrombotic, and renal complications upon admission to the ICU is unclear...
April 4, 2024: Current Obesity Reports
https://read.qxmd.com/read/38571543/assessment-of-the-activity-of-the-immune-system-in-patients-with-inflammatory-bowel-diseases-and-asymptomatic-covid-19
#24
JOURNAL ARTICLE
Michał Łodyga, Katarzyna Maciejewska, Kamila Stawczyk-Eder, Piotr Eder, Agnieszka Dobrowolska, Maria Wiśniewska-Jarosińska, Anita Gąsiorowska, Małgorzata Cicha, Grażyna Rydzewska
INTRODUCTION: Although the phenomenon of cytokine storm is well described in patients with severe COVID-19, little is known about the role of the immune system in asymptomatic patients, especially in the group with autoimmune diseases, such as inflammatory bowel disease (IBD). AIM: To assess the stimulation of the immune system expressed through the production of cytokines in IBD patients with asymptomatic COVID-19. MATERIAL AND METHODS: This is a multi-centre, prospective study in which the concentration of many cytokines (IL-1a, IL-1b, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12, IL-13, IL- 15, IL-17, IL-23, IFN-γ, TNF-α, TNF-β) was assessed in patients with IBD and asymptomatic SARS-CoV-2 infection diagnosed by serological tests...
2024: Przegla̜d Gastroenterologiczny
https://read.qxmd.com/read/38564364/l-ap-alleviates-liver-injury-in-septic-mice-by-inhibiting-macrophage-activation-via-suppressing-nf-%C3%AE%C2%BAb-and-nlrp3-inflammasome-caspase-1-signal-pathways
#25
JOURNAL ARTICLE
Linling Liu, Lan Lin, Yingling Wang, Xin Yan, Ruli Li, Min He, He Li, Caili Zhuo, Lingyu Li, Die Zhang, Xuemei Wang, Wenjing Huang, Xinyue Li, Yan Mao, Hongying Chen, Sisi Wu, Wei Jiang, Ling Zhu
Liver injury and progressive liver failure are severe life-threatening complications in sepsis, further worsening the disease and leading to death. Macrophages and their mediated inflammatory cytokine storm are critical regulators in the occurrence and progression of liver injury in sepsis, for which effective treatments are still lacking. l-Ascorbic acid 6-palmitate (L-AP), a food additive, can inhibit neuroinflammation by modulating the phenotype of the microglia, but its pharmacological action in septic liver damage has not been fully explored...
April 2, 2024: Journal of Agricultural and Food Chemistry
https://read.qxmd.com/read/38561936/clinical-outcomes-of-coronavirus-disease-in-patients-with-breast-cancer-treated-with-granulocyte-colony-stimulating-factor-following-chemotherapy-triangulation-of-evidence-using-population-based-cohort-and-mendelian-randomization-analyses
#26
JOURNAL ARTICLE
Yali Wang, Weifeng Cai, Peng He, Qindong Cai, Jinhua Huang, Shougui Liu, Minyan Chen, Lili Chen, Yuxiang Lin, Jialin Hou, Jing Li, Chengbin Fu, Zhonghua Han, Hui Han, Shunguo Lin, Chunsen Xu, Fangmeng Fu, Chuan Wang
Recombinant human granulocyte colony-stimulating factor (G-CSF) administration in patients with cancer and coronavirus disease (COVID-19) remains controversial. Concerns exist that it may worsen COVID-19 outcomes by triggering an inflammatory cytokine storm, despite its common use for managing chemotherapy-induced neutropenia (CIN) or febrile neutropenia post-chemotherapy. Here, we determined whether prophylactic or therapeutic G-CSF administration following chemotherapy exacerbates COVID-19 progression to severe/critical conditions in breast cancer patients with COVID-19...
April 1, 2024: International Journal of Cancer. Journal International du Cancer
https://read.qxmd.com/read/38559795/successful-treatment-of-hemophagocytic-lymphohistiocytosis-in-a-patient-with-systemic-lupus-erythematosus-with-ruxolitinib-a-case-report
#27
Ji In Jung, Ju Yeon Kim, Mi Hyeon Kim, Jin Kyun Park, Eun Young Lee, Eun Bong Lee, Jun Won Park
Hemophagocytic lymphohistiocytosis (HLH) is a rare, life-threatening hematological disorder characterized by uncontrolled activation of CD8+ T and natural killer cells, leading to a cytokine storm and severe organ dysfunction. Although secondary HLH related to autoimmune diseases usually demonstrates a good treatment response to immunosuppressive therapy for underlying conditions, there is no consensus regarding the treatment in case of unresponsiveness to the treatment. Herein, we present a case of HLH that was unresponsive to high-dose glucocorticoid and cyclosporine treatment in a patient with newly diagnosed systemic lupus erythematosus...
April 1, 2024: Journal of rheumatic diseases
https://read.qxmd.com/read/38558807/identification-of-mirnas-that-target-fc%C3%AE-receptor-mediated-phagocytosis-during-macrophage-activation-syndrome
#28
JOURNAL ARTICLE
Kontham Kulangara Varsha, Xiaoming Yang, Alkeiver S Cannon, Yin Zhong, Mitzi Nagarkatti, Prakash Nagarkatti
Macrophage activation syndrome (MAS) is a life-threatening complication of systemic juvenile arthritis, accompanied by cytokine storm and hemophagocytosis. In addition, COVID-19-related hyperinflammation shares clinical features of MAS. Mechanisms that activate macrophages in MAS remain unclear. Here, we identify the role of miRNA in increased phagocytosis and interleukin-12 (IL-12) production by macrophages in a murine model of MAS. MAS significantly increased F4/80+ macrophages and phagocytosis in the mouse liver...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38557089/does-your-unwell-patient-have-haemophagocytic-lymphohistiocytosis
#29
REVIEW
Amelia Holloway, Saad Ahmed, Jessica J Manson
Haemophagocytic lymphohistiocytosis is a severe systemic hyperinflammatory syndrome characterised by dysregulation of immune cells and excessive production of cytokines, also known as a cytokine storm. It has distinctive clinical features with fever, hyperferritinaemia and falling blood counts. In adults, this usually occurs secondary to an underlying driver or trigger including infection, malignancy or rheumatic diseases. Prompt treatment with immunomodulatory therapy, including corticosteroids and the recombinant IL-1 receptor antagonist anakinra, is recommended to switch off the cytokine storm...
March 2, 2024: British Journal of Hospital Medicine
https://read.qxmd.com/read/38555477/panoptosis-an-indicator-of-covid-19-severity-and-outcomes
#30
JOURNAL ARTICLE
Qingyuan Yang, Wanmei Song, Hanizaier Reheman, Dan Wang, Jieming Qu, Yanan Li
Coronavirus disease 2019 (COVID-19) has been wreaking havoc for 3 years. PANoptosis, a distinct and physiologically relevant inflammatory programmed cell death, perpetuates cytokine storm and multi-organ injuries in COVID-19. Although PANoptosis performs indispensable roles in host defense, further investigation is needed to elucidate the exact processes through which PANoptosis modulates immunological responses and prognosis in COVID-19. This study conducted a bioinformatics analysis of online single-cell RNA sequence (scRNA-seq) and bulk RNA-seq datasets to explore the potential of PANoptosis as an indicator of COVID-19 severity...
March 27, 2024: Briefings in Bioinformatics
https://read.qxmd.com/read/38555403/precision-nutrition-to-reset-virus-induced-human-metabolic-reprogramming-and-dysregulation-hmrd-in-long-covid
#31
REVIEW
A Satyanarayan Naidu, Chin-Kun Wang, Pingfan Rao, Fabrizio Mancini, Roger A Clemens, Aman Wirakartakusumah, Hui-Fang Chiu, Chi-Hua Yen, Sebastiano Porretta, Issac Mathai, Sreus A G Naidu
SARS-CoV-2, the etiological agent of COVID-19, is devoid of any metabolic capacity; therefore, it is critical for the viral pathogen to hijack host cellular metabolic machinery for its replication and propagation. This single-stranded RNA virus with a 29.9 kb genome encodes 14 open reading frames (ORFs) and initiates a plethora of virus-host protein-protein interactions in the human body. These extensive viral protein interactions with host-specific cellular targets could trigger severe human metabolic reprogramming/dysregulation (HMRD), a rewiring of sugar-, amino acid-, lipid-, and nucleotide-metabolism(s), as well as altered or impaired bioenergetics, immune dysfunction, and redox imbalance in the body...
March 30, 2024: NPJ science of food
https://read.qxmd.com/read/38550855/mice-myeloid-cells-and-dengue-a-new-model-for-unraveling-vascular-leakage-mysteries
#32
JOURNAL ARTICLE
Takeshi Kurosu, Yusuke Sakai, Yasusi Ami, Masayuki Shimojima, Tomoki Yoshikawa, Shuetsu Fukushi, Noriyo Nagata, Tadaki Suzuki, Hideki Ebihara, Masayuki Saijo
INTRODUCTION: Severe dengue is thought to be caused by an excessive host immune response. METHODS: To study the pathogenesis of severe dengue, we developed a novel model using LysM Cre+ Ifnar flox/flox mice carrying depleted Ifnar expression only in subsets of murine myeloid cells. RESULTS: Although dengue virus (DENV) clinical isolates were not virulent in LysM Cre+ Ifnar flox/flox mice, mouse-adapted DV1-5P7Sp and DV3P12/08P4Bm, which were obtained by passaging the spleen or bone marrow of mice, demonstrated 100% lethality with severe vascular leakage in the liver and small intestine...
2024: Frontiers in Microbiology
https://read.qxmd.com/read/38549864/impact-of-the-sars-cov-2-spike-protein-on-the-innate-immune-system-a-review
#33
REVIEW
Annelise Bocquet-Garçon
The Spike protein enables the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection by binding to multiple receptors, including the angiotensin-converting enzyme 2 (ACE2). Scientific studies also indicate that Spike is involved in severe forms of coronavirus disease 2019 (COVID-19), "long-haul COVID diseases" - also known as "long COVID syndromes" or "post-acute sequelae of SARS-CoV-2 infection" (PACS) - or, recently, in adverse reactions to lipid nanoparticle-messenger ribonucleic acid (mRNA) vaccines or other anti-COVID19 products...
March 2024: Curēus
https://read.qxmd.com/read/38544813/revolutionizing-treatment-strategies-for-autoimmune-and-inflammatory-disorders-the-impact-of-dipeptidyl-peptidase-4-inhibitors
#34
REVIEW
Kashif Rahim, Muhammad Shan, Ihtisham Ul Haq, Muhammad Naveed Nawaz, Sajida Maryam, Mansour S Alturki, Abdulaziz H Al Khzem, Kamel Metwally, Simona Cavalu, Saleh F Alqifari, Galal Yahya
DPP4 (Dipeptidyl-peptidase 4) a versatile protease, emerges as a prominent player in soluble and membrane-bound forms. Its heightened expression has been intimately linked to the initiation and severity of diverse autoimmune diseases, spanning rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis (SSc), inflammatory bowel disease, autoimmune diabetes, and even SARS-CoV-2 infection. Operating as a co-stimulator of T cell activity, DPP4 propels T cell proliferation by binding adenosine deaminase (ADA), thereby augmenting the breakdown of adenosine-an influential inhibitor of T cell proliferation...
2024: Journal of Inflammation Research
https://read.qxmd.com/read/38543837/an-evaluation-of-type-1-interferon-related-genes-in-male-and-female-matched-sars-cov-2-infected-individuals-early-in-the-covid-19-pandemic
#35
JOURNAL ARTICLE
Tom P Huecksteadt, Elizabeth J Myers, Samuel E Aamodt, Shubhanshi Trivedi, Kristi J Warren
SARS-CoV-2 infection has claimed just over 1.1 million lives in the US since 2020. Globally, the SARS-CoV-2 respiratory infection spread to 771 million people and caused mortality in 6.9 million individuals to date. Much of the early literature showed that SARS-CoV-2 immunity was defective in the early stages of the pandemic, leading to heightened and, sometimes, chronic inflammatory responses in the lungs. This lung-associated 'cytokine storm' or 'cytokine release syndrome' led to the need for oxygen supplementation, respiratory distress syndrome, and mechanical ventilation in a relatively high number of people...
March 20, 2024: Viruses
https://read.qxmd.com/read/38543815/small-molecules-for-the-treatment-of-long-covid-related-vascular-damage-and-abnormal-blood-clotting-a-patent-based-appraisal
#36
JOURNAL ARTICLE
Francesco Samarelli, Giovanni Graziano, Nicola Gambacorta, Elisabetta Anna Graps, Francesco Leonetti, Orazio Nicolotti, Cosimo Damiano Altomare
People affected by COVID-19 are exposed to, among others, abnormal clotting and endothelial dysfunction, which may result in deep vein thrombosis, cerebrovascular disorders, and ischemic and non-ischemic heart diseases, to mention a few. Treatments for COVID-19 include antiplatelet (e.g., aspirin, clopidogrel) and anticoagulant agents, but their impact on morbidity and mortality has not been proven. In addition, due to viremia-associated interconnected prothrombotic and proinflammatory events, anti-inflammatory drugs have also been investigated for their ability to mitigate against immune dysregulation due to the cytokine storm...
March 14, 2024: Viruses
https://read.qxmd.com/read/38540774/role-of-melatonin-in-viral-bacterial-and-parasitic-infections
#37
REVIEW
Georges J M Maestroni
In all mammals, the circulating pool of MLTs is synthesized in the pineal gland during the night's darkness hours. Its main function is synchronizing the organism in the photoperiod. In contrast, extra-pineal MLT is synthesized in peripheral organs, does not follow any circadian rhythm or circulate, and plays a detoxifying and cytoprotective role. Circulating MLT may stimulate both innate and acquired immune responses through its circadian action and by activating high-affinity receptors on immunocompetent cells...
March 16, 2024: Biomolecules
https://read.qxmd.com/read/38539816/intratracheal-administration-of-stem-cell-membrane-cloaked-naringin-loaded-biomimetic-nanoparticles-promotes-resolution-of-acute-lung-injury
#38
JOURNAL ARTICLE
Hua Jin, Yue Zhao, Yinlian Yao, Shilong Fan, Renxing Luo, Xin Shen, Yanyan Wang, Jiang Pi, Gonghua Huang
Cytokine storm and ROS overproduction in the lung always lead to acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) in a very short time. Effectively controlling cytokine storm release syndrome (CRS) and scavenging ROS are key to the prevention and treatment of ALI/ARDS. In this work, the naringin nanoparticles (Nar-NPs) were prepared by the emulsification and evaporation method; then, the mesenchymal stem cell membranes (CMs) were extracted and coated onto the surface of the Nar-NPs through the hand extrusion method to obtain the biomimetic CM@Nar-NPs...
February 26, 2024: Antioxidants (Basel, Switzerland)
https://read.qxmd.com/read/38536545/early-sevoflurane-sedation-in-severe-covid-19-related-lung-injury-patients-a-pilot-randomized-controlled-trial
#39
JOURNAL ARTICLE
Beatrice Beck-Schimmer, Erik Schadde, Urs Pietsch, Miodrag Filipovic, Seraina Dübendorfer-Dalbert, Patricia Fodor, Tobias Hübner, Reto Schuepbach, Peter Steiger, Sascha David, Bernard D Krüger, Thomas A Neff, Martin Schläpfer
BACKGROUND: This study aimed to assess a potential organ protective effect of volatile sedation in a scenario of severe inflammation with an early cytokine storm (in particular IL-6 elevation) in patients suffering from COVID-19-related lung injury with invasive mechanical ventilation and sedation. METHODS: This is a small-scale pilot multicenter randomized controlled trial from four tertiary hospitals in Switzerland, conducted between April 2020 and May 2021. 60 patients requiring mechanical ventilation due to severe COVID-19-related lung injury were included and randomized to 48-hour sedation with sevoflurane vs...
March 27, 2024: Annals of Intensive Care
https://read.qxmd.com/read/38532628/in-vitro-and-in-vivo-validation-of-the-antiviral-effect-of-hcypa-against-sars-cov-2-via-binding-to-the-rbd-of-spike-protein
#40
JOURNAL ARTICLE
Woo-Ri Shin, Do-Young Kim, Sang Yong Kim, Gna Ahn, Dae-Young Park, Jiho Min, Ji-Young Ahn, Yang-Hoon Kim
The novel coronavirus disease 2019 has stimulated the rapid development of new biological therapeutics to inhibit SARS-CoV-2 infection; however, this remains a challenging task. In a previous study using structural analysis, we revealed that human cyclophilin A inhibits the entry of SARS-CoV-2 into host cells by interfering with the interaction of the receptor-binding domain of the spike protein with angiotensin-converting enzyme 2 on the host cell surface, highlighting its potential for antiviral therapy. For a comprehensive experimental validation, in this study, we verified the antiviral effects of human cyclophilin A against SARS-CoV-2, including its variants, using in vitro assays and experiments on an in vivo mouse model...
March 25, 2024: Molecular Therapy
keyword
keyword
69831
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.